制酸薬の世界市場レポート 2024

制酸薬の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には3.7%の年間複合成長率（CAGR）で110億米ドルに成長すると予想されています。 制酸薬市場の予測期間で予想される成長は、市場競争と業界の動向、消費者の好みとブランドロイヤルティの進化、健康の選択に影響を与える環境への配慮とライフスタイルの変化、新しい健康状態の出現、経済状況などの要因に起因する可能性があり、医療支出に影響を与えます。予測期間に予想される主な動向には、消費者の健康意識と意識の高まり、制酸薬製剤の技術進歩、自然療法の選好、製薬業界における規制の変更とコンプライアンス、制酸薬の需要に寄与する消化器疾患の発生率の増加などが含まれます。

制酸薬市場の成長は不適切なライフスタイルの選択に大きく影響され、酸性度の増加につながります。座りっぱなしの仕事、不十分な睡眠の質、不規則な食生活などの不健康なライフスタイルは、胃酸レベルの上昇に寄与し、胃食道逆流症（GERD）などの症状を引き起こします。 American College of Gastroenterologyの報告によると、約6,000万人のアメリカ人が胃食道逆流症に苦しんでおり、制酸薬の需要が高まっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 市場促進要因・市場抑制要因
  • 市場促進要因
  • 市場抑制要因
• 市場規模と成長実績、2018～2023年
• 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の制酸薬市場、薬剤クラス別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• プロトンポンプ阻害薬
• H2拮抗薬
• 酸中和剤
• 運動促進剤
• 世界の制酸薬市場、製剤タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 錠剤
• 液体
• 粉末
• その他
• 世界の制酸薬市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院薬局
• 小売薬局
• その他

第7章 地域および国の分析

• 世界の制酸薬市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の制酸薬市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 制酸薬市場の競合情勢
• 制酸薬市場の企業プロファイル
  • Walmart Equate LLC
  • Private Label
  • Pfizer Inc
  • Johnson & Johnson Services Inc.
  • Procter & Gamble Co.

第31章 その他の大手および革新的な企業

• Bayer AG
• Novartis AG
• Sanofi SA
• Bristol Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim GmbH
• Reckitt Benckiser Group plc
• WellSpring Pharmaceutical Corporation
• Xiuzheng Pharmaceutical Group Company Limited
• Bausch Health Companies Inc.
• Sun Pharmaceuticals Industries Ltd.
• Dr. Reddy's Laboratories Ltd

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Antacid drugs are medications used to neutralize stomach acid, providing relief from conditions such as acid reflux, heartburn, and indigestion. They counteract the stomach's acid, easing symptoms, and are available without a prescription in liquid or chewable tablet form. The drug classes within antacids include proton pump inhibitors, H2 antagonists, surgical simulators, and acid neutralizers, available in tablets, liquid, or powder forms.

The primary classes of antacids are proton pump inhibitors, H2 antagonists, acid neutralizers, and pro-motility agents. Proton pump inhibitors significantly and for an extended period reduce stomach acid production by irreversibly blocking the H+/K+ ATPase proton pump in the stomach. Antacids come in various formulations, including tablets, liquids, powders, and others, and are distributed through channels such as hospital pharmacies, retail pharmacies, and other outlets.

The antacids market research report is one of a series of new reports from The Business Research Company that provides antacids market statistics, including antacids industry global market size, regional shares, competitors with an antacids market share, detailed antacids market segments, market trends, and opportunities, and any further data you may need to thrive in the antacids industry. This antacids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antacids market size has grown steadily in recent years. It will grow from $9.16 billion in 2023 to $9.52 billion in 2024 at a compound annual growth rate (CAGR) of 3.9%. The growth observed during the historical period in the antacids market can be attributed to factors such as historical pricing and accessibility of antacid medications, shifts in dietary habits over time, economic conditions and lifestyle changes influencing healthcare choices, advancements in medical understanding and awareness of gastrointestinal conditions, and historical population demographics shaping the prevalence of acid-related issues.

The antacids market size is expected to see steady growth in the next few years. It will grow to $11 billion in 2028 at a compound annual growth rate (CAGR) of 3.7%. The anticipated growth in the forecast period in the antacids market can be attributed to factors such as market competition and industry trends, evolving consumer preferences and brand loyalty, environmental considerations and lifestyle changes affecting health choices, the emergence of new health conditions, and economic conditions influencing healthcare spending. Major trends expected in the forecast period include increased health consciousness and awareness among consumers, technological advancements in antacid formulations, a preference for natural remedies, regulatory changes and compliance in the pharmaceutical industry, and a rising incidence of digestive disorders contributing to the demand for antacid medications.

The growth of the antacids market is significantly influenced by poor lifestyle choices, leading to a higher prevalence of acidity. Unhealthy lifestyle practices, such as sedentary jobs, inadequate sleep quality, and irregular dietary habits, contribute to elevated stomach acidity levels, resulting in conditions such as gastroesophageal reflux disease (GERD). The American College of Gastroenterology reports that approximately 60 million Americans suffer from GERD, fueling the demand for antacids.

The anticipated increase in the prevalence of inflammatory bowel disease is expected to drive the growth of the animal growth promoters and performance enhancers market. Inflammatory bowel disease (IBD) encompasses a group of conditions characterized by chronic inflammation in the digestive tract. Antacids, designed to regulate stomach acid levels, are commonly used for managing heartburn and indigestion. According to the International Foundation for Gastrointestinal Disorders (IFFGD), it is projected that 5-10% of the global population will have irritable bowel syndrome (IBS) by 2023, affecting between 25 and 45 million people in the United States. Additionally, a survey by the American Gastroenterological Association covering 33 countries on 6 continents revealed that more than 40% of adult respondents worldwide have functional gastrointestinal disorders (FGID), impacting their quality of life and healthcare utilization. Consequently, the increasing prevalence of inflammatory bowel disease is expected to propel the growth of the animal growth promoters and performance enhancers market in the future.

The antacids market faces a major restraint in the form of side effects associated with these medications. Common side effects include dose-dependent rebound hyperacidity and milk-alkali syndrome. Antacids containing aluminum hydroxide may lead to issues such as constipation, aluminum intoxication, osteomalacia, and hypophosphatemia. Additionally, when consumed with other acidic drugs, antacids may result in reduced efficacy of both drugs due to drug absorption interactions.

An emerging trend in the antacid market is the development of mouth-melting antacids. Traditionally available in tablet, liquid, and powder forms, mouth-melting antacids utilize micro-mouth melting granules that easily dissolve in the mouth. Sunpharma's 'Pepmelt' is an example of a mouth-melting instant relief antacid that combines herbal constituents with contemporary mouth-melting technology.

Major companies in the antacids market are diversifying their product offerings by introducing multiple antacid flavors to enhance market profitability. Antacid flavors refer to the various tastes available for antacid products. Wonderbelly, a US-based digestive medicine company, introduced three antacid flavors, namely Fruity Cereal (exclusive to Target stores), Strawberry Milkshake, and Watermelon Mint, in March 2023. Wonderbelly's Antacid, containing calcium carbonate as its active ingredient, distinguishes itself as a non-GMO and vegan product without talc, dyes, gluten, dairy, common allergens, synthetic sweeteners, artificial flavors, parabens, and preservatives. Developed in collaboration with gastroenterologists and pharmaceutical manufacturers, these products prioritize quality.

In the United States, manufacturers of antacids are required to comply with the Code of Federal Regulations Title 21 established by the FDA. According to these regulations, over-the-counter (OTC) antacid products in forms suitable for oral administration are deemed safe and effective only if they meet the conditions related to active ingredients specified by the FDA.

Major companies operating in the antacids market report are Walmart Equate LLC, Private Label, Pfizer Inc., Johnson & Johnson Services Inc., Procter & Gamble Co., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Reckitt Benckiser Group PLC, WellSpring Pharmaceutical Corporation, Xiuzheng Pharmaceutical Group Company Limited, Bausch Health Companies Inc., Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Alkem Laboratories Ltd., Conba Group Co. Ltd., Chattem Chemicals Inc., China Resources Sanjiu Medical & Pharmaceutical Co. Ltd., Thornton and Ross Ltd., McNeil Consumer Pharmaceuticals Co., Advance Pharmaceutical Inc.

North America was the largest region in the antacids market in 2023. The Middle East is expected to be the fastest-growing region in the global antacids market share. The regions covered in the antacids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antacids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The antacids market consists of sales of Alka Seltzer, Maalox, Mylanta, Rolaids, Tums, and Pepto-Bismol. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antacids Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antacids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antacids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antacids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Drug Class: Proton Pump Inhibitors; H2 Antagonist; Acid Neutralizers; Pro-Motility Agents
• 2) By Formulation Type: Tablet; Liquid; Powder; Other Formulation Types
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
• Companies Mentioned: Walmart Equate LLC; Private Label; Pfizer Inc; Johnson & Johnson Services Inc.; Procter & Gamble Co.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antacids Market Characteristics

3. Antacids Market Trends And Strategies

4. Antacids Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Antacids Market Size and Growth

• 5.1. Global Antacids Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Antacids Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Antacids Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Antacids Market Segmentation

• 6.1. Global Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Proton Pump Inhibitors
• H2 Antagonist
• Acid Neutralizers
• Pro-Motility Agents
• 6.2. Global Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Tablet
• Liquid
• Powder
• Other Formulation Types
• 6.3. Global Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channels

7. Antacids Market Regional And Country Analysis

• 7.1. Global Antacids Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Antacids Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Antacids Market

• 8.1. Asia-Pacific Antacids Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Antacids Market

• 9.1. China Antacids Market Overview
• 9.2. China Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Antacids Market

• 10.1. India Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Antacids Market

• 11.1. Japan Antacids Market Overview
• 11.2. Japan Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Antacids Market

• 12.1. Australia Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Antacids Market

• 13.1. Indonesia Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Antacids Market

• 14.1. South Korea Antacids Market Overview
• 14.2. South Korea Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Antacids Market

• 15.1. Western Europe Antacids Market Overview
• 15.2. Western Europe Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Antacids Market

• 16.1. UK Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Antacids Market

• 17.1. Germany Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Antacids Market

• 18.1. France Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Antacids Market

• 19.1. Italy Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Antacids Market

• 20.1. Spain Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Antacids Market

• 21.1. Eastern Europe Antacids Market Overview
• 21.2. Eastern Europe Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Antacids Market

• 22.1. Russia Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Antacids Market

• 23.1. North America Antacids Market Overview
• 23.2. North America Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Antacids Market

• 24.1. USA Antacids Market Overview
• 24.2. USA Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Antacids Market

• 25.1. Canada Antacids Market Overview
• 25.2. Canada Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Antacids Market

• 26.1. South America Antacids Market Overview
• 26.2. South America Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Antacids Market

• 27.1. Brazil Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Antacids Market

• 28.1. Middle East Antacids Market Overview
• 28.2. Middle East Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Antacids Market

• 29.1. Africa Antacids Market Overview
• 29.2. Africa Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Antacids Market Competitive Landscape And Company Profiles

• 30.1. Antacids Market Competitive Landscape
• 30.2. Antacids Market Company Profiles
  • 30.2.1. Walmart Equate LLC
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Private Label
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Pfizer Inc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Johnson & Johnson Services Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Procter & Gamble Co.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Antacids Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Novartis AG
• 31.3. Sanofi S.A.
• 31.4. Bristol Myers Squibb Company
• 31.5. AstraZeneca plc
• 31.6. Abbott Laboratories
• 31.7. GlaxoSmithKline plc
• 31.8. Takeda Pharmaceutical Company Limited
• 31.9. Boehringer Ingelheim GmbH
• 31.10. Reckitt Benckiser Group plc
• 31.11. WellSpring Pharmaceutical Corporation
• 31.12. Xiuzheng Pharmaceutical Group Company Limited
• 31.13. Bausch Health Companies Inc.
• 31.14. Sun Pharmaceuticals Industries Ltd.
• 31.15. Dr. Reddy's Laboratories Ltd

32. Global Antacids Market Competitive Benchmarking

33. Global Antacids Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Antacids Market

35. Antacids Market Future Outlook and Potential Analysis

• 35.1 Antacids Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Antacids Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Antacids Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer